Literature DB >> 29686155

Identification of Novel Mutations in LprG (rv1411c), rv0521, rv3630, rv0010c, ppsC, and cyp128 Associated with Pyrazinoic Acid/Pyrazinamide Resistance in Mycobacterium tuberculosis.

Wanliang Shi1, Jiazhen Chen2, Shuo Zhang1, Wenhong Zhang2, Ying Zhang3.   

Abstract

Despite progress, the mechanisms of action and resistance of pyrazinamide (PZA) are not well understood. We characterized 109 mutants resistant to pyrazinoic acid (POA), the active form of PZA, and found that while most (n = 101 [93%]) mutants had panD mutations and 4 (4%) had clpC1 mutations (S91G), new mutations in lprG (rv1411c) and rv0521 (n = 4 [4%]), rv3630, rv0010c, ppsC, and cyp128 (cytochrome P450 128) were identified, shedding new light on the mechanisms of action and resistance of PZA in M. tuberculosis.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  antibiotic resistance; pyrazinamide; tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 29686155      PMCID: PMC6021685          DOI: 10.1128/AAC.00430-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?

Authors:  Jim Werngren; Erik Alm; Mikael Mansjö
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.

Authors:  S J Cheng; L Thibert; T Sanchez; L Heifets; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 3.  Mechanisms of Pyrazinamide Action and Resistance.

Authors:  Ying Zhang; Wanliang Shi; Wenhong Zhang; Denis Mitchison
Journal:  Microbiol Spectr       Date:  2014-08

4.  Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.

Authors:  A Scorpio; P Lindholm-Levy; L Heifets; R Gilman; S Siddiqi; M Cynamon; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.

Authors:  A Scorpio; Y Zhang
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

Review 6.  The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.

Authors:  Kirsty J McLean; James Belcher; Max D Driscoll; Christine C Fernandez; Duyet Le Van; Soi Bui; Marina Golovanova; Andrew W Munro
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

7.  Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis.

Authors:  Shuo Zhang; Jiazhen Chen; Wanliang Shi; Wei Liu; Wenhong Zhang; Ying Zhang
Journal:  Emerg Microbes Infect       Date:  2013-06-12       Impact factor: 7.163

8.  Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.

Authors:  Wanliang Shi; Jiazhen Chen; Jie Feng; Peng Cui; Shuo Zhang; Xinhua Weng; Wenhong Zhang; Ying Zhang
Journal:  Emerg Microbes Infect       Date:  2014-08-13       Impact factor: 7.163

9.  Mycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosis.

Authors:  Amanda J Martinot; Mary Farrow; Lu Bai; Emilie Layre; Tan-Yun Cheng; Jennifer H Tsai; Jahangir Iqbal; John W Annand; Zuri A Sullivan; M Mahmood Hussain; James Sacchettini; D Branch Moody; Jessica C Seeliger; Eric J Rubin
Journal:  PLoS Pathog       Date:  2016-01-11       Impact factor: 6.823

10.  Mutation in clpC1 encoding an ATP-dependent ATPase involved in protein degradation is associated with pyrazinamide resistance in Mycobacterium tuberculosis.

Authors:  Shuo Zhang; Jiazhen Chen; Wanliang Shi; Peng Cui; Jia Zhang; Sanghyun Cho; Wenhong Zhang; Ying Zhang
Journal:  Emerg Microbes Infect       Date:  2017-02-15       Impact factor: 7.163

View more
  7 in total

Review 1.  Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide.

Authors:  Pooja Gopal; Gerhard Grüber; Véronique Dartois; Thomas Dick
Journal:  Trends Pharmacol Sci       Date:  2019-11-06       Impact factor: 14.819

Review 2.  The Bewildering Antitubercular Action of Pyrazinamide.

Authors:  Elise A Lamont; Nicholas A Dillon; Anthony D Baughn
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

Review 3.  Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.

Authors:  Erik M Larsen; R Jeremy Johnson
Journal:  Drug Dev Res       Date:  2018-10-10       Impact factor: 4.360

4.  Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.

Authors:  Tomotada Iwamoto; Yoshiro Murase; Shiomi Yoshida; Akio Aono; Makoto Kuroda; Tsuyoshi Sekizuka; Akifumi Yamashita; Kengo Kato; Takemasa Takii; Kentaro Arikawa; Seiya Kato; Satoshi Mitarai
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

5.  Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China.

Authors:  Kun Li; Zhongping Yang; Jing Gu; Ming Luo; Jiaoyu Deng; Yaokai Chen
Journal:  Front Microbiol       Date:  2021-01-11       Impact factor: 5.640

Review 6.  Progress Report: Antimicrobial Drug Discovery in the Resistance Era.

Authors:  Pottathil Shinu; Abdulaziz K Al Mouslem; Anroop B Nair; Katharigatta N Venugopala; Mahesh Attimarad; Varsha A Singh; Sreeharsha Nagaraja; Ghallab Alotaibi; Pran Kishore Deb
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-28

7.  Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China.

Authors:  Hm Adnan Hameed; Yaoju Tan; Md Mahmudul Islam; Zhili Lu; Chiranjibi Chhotaray; Shuai Wang; Zhiyong Liu; Cuiting Fang; Shouyong Tan; Wing Wai Yew; Nanshan Zhong; Jianxiong Liu; Tianyu Zhang
Journal:  Infect Drug Resist       Date:  2020-01-22       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.